Mamedyarov Zaur
Public Innovation Policy in the Pharmaceutical Industry: the Cases of the EU and USA
DOI 10.18184/2079-4665.2017.8.1.105-114
Public Innovation Policy in the Pharmaceutical Industry: the Cases of the EU and USA
Publication Type:
DOI 10.18184/2079-4665.2017.8.1.105-114
Russian Science Citation Index
OTHER PUBLICATIONS ON THIS TOPIC
Pankova Ludmila
Evolution of the USA Defense Research and Development: Amount and Structure of Financing
Kutsyna Elena
Системный подход к исследованию инноваций в военно-промышленном комплексе развитых стран / Е.А. Куцына // Вооружение и экономика. – 2011. – № 15. – С. 63-72.
Yevtodyeva Marianna
Japan: New Trends in Research and Development of Defense and Dual-Use Technologies
Bogacheva Olga
Актуальные вопросы организации государственного финансирования НИОКР в странах ОЭСР [Текст] / О. В. Богачева, О. В. Смородинов // Научно-исследовательский финансовый институт. Финансовый журнал. – 2019. – № 2 (48). – С. 37-50. DOI: 10.31107/2075-1990-2019-2-37-50.
Kutsyna Elena
R&D and innovation in the military sector of the United Kingdom economy. Moscow, IMEMO PAN, 2014. – 42 p.
Kudrov Valentin
Выход из кризиса и инновационная модель экономики [Текст] / В.М. Кудров // Общественные науки и современность. – 2013. – № 4. – С. 5 – 15.
Selyanin Yaroslav
Management System in the U.S.: the Case of AI-Related Projects // USA & Canada: Economics – Politics – Culture. – 2022. – Issue 9 C. 95-113 .
Kutsyna Elena
The innovative activity as an element of the military and economic preparations / Kutsyna Elena A.
Gusarova Olga
The R&D Contracting System in the UK Defense and Security
Gilkova Olga
Милитаризация науки и ее влияние на развитие экономики [Текст] / О. Н Гилькова // Современная наука: актуальные проблемы теории и практики. Серия: экономика и право. – 2018. – № 1. – С. 78-81.
Bogacheva Olga, Smorodinov O.
Criteria for formation of public financial support system for R&D projects with the participation of business
Bogacheva Olga, Feoktistova O.A.
State R&D Assignments: Approach to Determining their Budgets Based Normative Costs
Mamedyarov Zaur
Pharmaceutical Industry Development in the Midst of Crisis: Global Trends. MIR (Modernization. Innovation. Research). 2020;11(4):398-408. https://doi.org/10.18184/2079-4665.2020.11.4.398-408
Bogacheva Olga
Defining the main types of research and development for purposes of shaping state R&D policy in Russia and in OECD countries
Danilin Ivan
Transformation of the U.S. Model of State Science and Technology Policy: from G. Bush to B. Obama. Moscow, Ideya-PRESS, 2009. 64 p.
The Priorities of the Foreign Dual-Use R&D / Pankova L.V., Kazennov S.Yu., eds. – Moscow, IMEMO, 2016. – 236 p.
Kuznetsov Alexey
Organizational Measures for the Growth of Research Efficiency in Russia / Kuznetsov Alexey
Mamedyarov Zaur
Тенденции и перспективы российской фармацевтической отрасли и применимость мирового опыта [Текст] / З.А. Мамедьяров // МИР (Модернизация. Инновации. Развитие). – 2017. – Т. 8. – № 4s(32s). – С. 772-780.
Bogacheva Olga, Feoktistova O.A.
Methodological approaches to assessing the standard costs for R&D
Danilin Ivan
Public Science and Technology Policy of the USA. Moscow, IMEMO RAN, 2004. 113 p.
Related publications
No comments